[Form 4] Amalgamated Financial Corp. Insider Trading Activity

Rhea-AI Filing Summary

Amalgamated Financial Corp. insider Mandy Tenner, who is identified as the company's EVP and Chief Legal Officer, reported sales of common stock on 08/07/2025. The Form 4 shows two blocks sold: 1,576 shares and 3,666 shares, for a total of 5,242 shares disposed.

The filing reports weighted-average prices for the trades at approximately $27.4599 and $27.4583, with disclosed execution price ranges of $27.61–$27.33 and $27.59–$27.35. The reported beneficial ownership figures following the transactions include amounts shown as 16,577.24 and 12,911.24 shares, and the filings note that those totals incorporate 39 shares from the company ESPP and 17.24 shares from the dividend reimbursement plan.

Positive

• Transparent disclosure of weighted-average prices and execution ranges for the sales, with an undertaking to provide detailed per-price allocations on request
• Beneficial ownership totals are disclosed and explicitly note inclusion of 39 ESPP shares and 17.24 dividend-reimbursement shares, improving clarity

Negative

• Insider disposal of a total of 5,242 common shares (1,576 and 3,666 shares), which reduces the reporting person's direct holdings
• Sales occurred on 08/07/2025 at prices near $27.46, which investors may view as signaling liquidity needs or portfolio rebalancing

Insights

Corporate Governance Expert

TL;DR: Executive sold 5,242 shares in two blocks at ~ $27.46; disclosure includes ESPP and dividend-plan shares in post-sale totals.

The sales are clearly disclosed and accompanied by weighted-average prices and execution ranges, which enhances transparency. The reporting person remains an officer and reports substantial residual holdings per the form. Because the filing includes specific price ranges and confirms availability of detailed allocation information on request, corporate governance standards for Section 16 disclosures are met.

Securities Analyst

TL;DR: Insider sales of 5,242 shares at roughly $27.46 reduce holdings but are routine based on the filing's footnotes.

The transaction sizes (1,576 and 3,666 shares) and reported weighted-average prices are explicit. Footnote detail that 39 ESPP shares and 17.24 dividend-reimbursement shares are included in reported totals helps clarify reported beneficial ownership. There is no additional context in the filing about intent or planned sales, so the market impact is likely limited absent other material disclosures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tenner Mandy

(Last) (First) (Middle)

275 SEVENTH AVE

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amalgamated Financial Corp. [ AMAL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2025		S		1,576	D	$27.4599(1)	16,577.24(2)	D
Common Stock	08/07/2025		S		3,666	D	$27.4583(3)	12,911.24	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.61 - $27.33. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

2. The total reported in Column 5 of this Form 4 includes 39 shares of common stock, acquired by the reporting person under the Company's employee stock purchase program, in Q1 of 2025, and 17.24 shares of common stock, acquired by the reporting person under the Company's dividend reimbursement plan, in Q2 of 2025.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.59 - $27.35. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Remarks:

	/s/ Mandy Tenner	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did AMAL insider Mandy Tenner report on the Form 4?

The Form 4 reports sales of 1,576 and 3,666 shares of AMAL common stock (total 5,242 shares) on 08/07/2025.

At what prices were the AMAL shares sold by Mandy Tenner?

The filing shows weighted-average prices of approximately $27.4599 and $27.4583, with execution ranges of $27.61–$27.33 and $27.59–$27.35.

What is Mandy Tenner's role at Amalgamated Financial (AMAL)?

The Form 4 identifies Mandy Tenner as an Officer with the title EVP, Chief Legal Officer.

Does the filing explain the composition of post-transaction beneficial ownership?

Yes. Footnote states the reported totals include 39 shares from the employee stock purchase program and 17.24 shares from the dividend reimbursement plan.

How many shares remain reported as beneficially owned after the transactions?

The form presents reported post-transaction figures of 16,577.24 and 12,911.24 shares in the relevant columns of the filing.